Analysis of salivary alpha-L-fucosidase and salic acid among oral sub-mucous fibrosis patients.

Sayan Mitra, Satish Gujjarlapudi, Nishath Sayed Abdul, Pallavi Singh, Debanti Giri, Ekta Pansheriya, Ramanpal Singh Makkad

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Bioinformation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sayan MitraDepartment of Oral Medicine and Radiology, RKDF Dental College, Bhopal, M.P., India.

Satish GujjarlapudiDMD,MBS,BDS, Associate Dentist, Familia dental, 804 S Green River road, Evansville, IN 47715.

Nishath Sayed AbdulFaculty of Oral Pathology, Department of OMFS and Diagnostic Sciences, College of Medicine and Dentistry, Riyadh Elm University, Riyadh, Kingdom of Saudi Arabia.

Pallavi SinghReader & Head, Department of Public Health Dentistry, Saraswati Dental College & Hospital, Lucknow, U.P.

Debanti GiriAssociate Professor, Department of Oral Medicine and Radiology, Dr R Ahmed Dental College and Hospital ,West Bengal, India.

Ekta PansheriyaDepartment of Pedodontics and Preventive Dentistry, Faculty of Dental Science, Dharmsinh Desai University, Nadiad.

Ramanpal Singh MakkadDepartment of Oral Medicine and Radiology, New Horizon Dental College and Research Institute, Bilaspur, Chhattisgarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The salivary concentrations of alpha L fucosidase (AFU) and salic acid (SA) in oral submucous fibrosis patients and compare it with healthy controls is of interest to dentists. 40 patients of OSMF and 40 healthy controls were included. Estimation of AFU and SA in saliva and serum was carried out in every patient. The serum level of AFU was 37.4±26.8 in OSMF patients and saliva level of AFU was 35.4±14.5. The serum level of AFU was 19.2±4.3 in control group and saliva level of AFU was 35.4±14.5 in control group. The serum level of SA was 20.32±2.71 in OSMF patients and saliva level of SA was 18.21±2.40. The serum level of SA was 4.89 ±1.17 in control group and saliva level of SA was 3.13 ±1.04 in control group. Estimation of concentration of SA and AFU in saliva can be effective biomarker in diagnosis of OSMF.

Indexed as

alpha L fucosidasesalic acidsaliva

Identifiers

PMID39131533

DOI10.6026/973206300200669

PMCPMC11312311

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.